Gilead Sciences
GILD
#111
Rank
NZ$285.56 B
Marketcap
NZ$230.07
Share price
-1.29%
Change (1 day)
33.26%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): NZ$16.76 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are NZ$29.44 Billion. , an increase over its 2024 earnings that were of NZ$1.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 NZ$16.58 B1319.86%
2024 NZ$1.16 B-89.94%
2023 NZ$11.61 B17.97%
2022 NZ$9.84 B-29.77%
2021 NZ$14.01 B395.99%
2020 NZ$2.82 B-67.66%
2019 NZ$8.73 B-33.84%
2018 NZ$13.20 B-42.35%
2017 NZ$22.90 B-20.87%
2016 NZ$28.95 B-21.06%
2015 NZ$36.67 B45.8%
2014 NZ$25.15 B253.01%
2013 NZ$7.12 B16.51%
2012 NZ$6.11 B-1.07%
2011 NZ$6.18 B-6.71%
2010 NZ$6.62 B11.75%
2009 NZ$5.92 B29.5%
2008 NZ$4.57 B19.11%
2007 NZ$3.84 B-455.74%
2006 -NZ$1.09 Billion-154.93%
2005 NZ$1.96 B76.99%
2004 NZ$1.11 B-266.16%
2003 -NZ$0.67 Billion-638.24%
2002 NZ$0.12 B31.5%
2001 NZ$94.51 M-242.15%
2000 -NZ$66.5 Million-40.2%
1999 -NZ$0.12 Billion31.85%
1998 -NZ$84.33 Million8.73%
1997 -NZ$77.56 Million27.22%
1996 -NZ$60.96 Million
1994 -NZ$58.09 Million26.57%
1993 -NZ$45.89 Million46.49%
1992 -NZ$31.33 Million362.5%
1991 -NZ$6.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$56.81 B 242.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$17.25 B 4.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$11.17 B-32.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$43.57 B 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.19 B-8.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.63 B-84.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$2.00 B-87.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$7.88 B-52.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$37.96 B 128.88%๐Ÿ‡บ๐Ÿ‡ธ USA